Weight Management Plus LNG-IUS/Megestrol Acetate in Endometrial Atypical Hyperplasia
Status:
Not yet recruiting
Trial end date:
2026-02-28
Target enrollment:
Participant gender:
Summary
To investigate the efficacy of weight management plus levonorgestrel intrauterine system
(LNG-IUS) or megestrol acetate (MA) in obese patients with endometrial atypical hyperplasia
(EAH) asking for conservative therapy.